Industry Trends & Resources

Global Clinical Trial Support: Connecting Across Borders

Global Clinical Trial Support: Connecting Across Borders

Connecting Patients, Sites and Study Teams Across Borders Clinical trials are becoming increasingly global. Patients may travel across cities, states, or even international borders to access specialized treatments and participate in studies. While expanding a trial geographically can help sponsors reach more diverse patient populations, it also introduces another layer

Read More »
Πληρωμές και Αποζημιώσεις Ασθενών

Μια πιο έξυπνη προσέγγιση στις πληρωμές και αποζημιώσεις ασθενών

Patient Payments and Reimbursements Clinical trial participation can require a significant investment of time, travel, and personal resources from patients and their caregivers. Even when a study offers an important opportunity to access new treatments or advance medical research, out-of-pocket expenses can create an additional barrier to participation. Travel costs,

Read More »
Πλοήγηση στην Επιχειρησιακή Πραγματικότητα των Ογκολογικών Κλινικών Μελετών: Γιατί ο Σχεδιασμός Ταξιδιών & Εξόδων έχει σημασία για τους Χορηγούς

Πλοήγηση στην Επιχειρησιακή Πραγματικότητα των Ογκολογικών Κλινικών Μελετών

Navigating the Operational Reality of Oncology Trials: Why Travel & Expense Design Matters to Sponsors Oncology clinical trials are designed around scientific rigor, regulatory precision, and the promise of advancing care. But beneath the protocol design and endpoints sits a quieter determinant of success: whether participants can realistically stay engaged

Read More »
Μήνας Ευαισθητοποίησης για το Σάρκωμα: Προάγοντας την Ελπίδα μέσω της Έρευνας

Μήνας Ευαισθητοποίησης για το Σάρκωμα: Προάγοντας την Ελπίδα μέσω της Έρευνας

Sarcoma Awareness Month: Advancing Hope Through Research, Collaboration, and Clinical Trials Every July, Sarcoma Awareness Month brings attention to one of the rarest and most diverse forms of cancer while recognizing the patients, families, clinicians, researchers, and advocates dedicated to improving outcomes. Sarcomas account for approximately 1% of adult cancers

Read More »
Μετάβαση στο περιεχόμενο